Physician profile
John Y Hess
NPI 1053504910
$1,707.92
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $899 · 2020: $657 · 2022: $151.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $368.12 | 2019-2020 | |
| Abbott Laboratories | $364.98 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $233.55 | 2019-2020 | |
| Amarin Pharma, INC. | $130.46 | 2019-2020 | |
| Medtronic Vascular, INC. | $127.35 | 2019-2020 | |
| Edwards Lifesciences Corporation | $99.85 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $94.97 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $47.55 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $39.44 | 2019 | |
| Gilead Sciences, INC. | $33.46 | 2019 | |
| Janssen Pharmaceuticals, INC | $31.30 | 2020 | |
| Sanofi-Aventis U.S. LLC | $24.65 | 2019 | |
| Boston Scientific Corporation | $24.06 | 2020 | |
| Arbor Pharmaceuticals, INC. | $18.91 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $18.12 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $16.68 | 2020 | |
| Actelion Pharmaceuticals US, INC. | $14.76 | 2019 | |
| Tactile Systems Technology INC | $14.14 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $5.57 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Hess listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.